These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 27838299)

  • 1. Structure-activity relationships of ω-Agatoxin IVA in lipid membranes.
    Ryu JH; Jung HJ; Konishi S; Kim HH; Park ZY; Kim JI
    Biochem Biophys Res Commun; 2017 Jan; 482(1):170-175. PubMed ID: 27838299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-affinity blockade of neuronal N-type Ca channels by the spider toxin omega-agatoxin-IVA.
    Sidach SS; Mintz IM
    J Neurosci; 2000 Oct; 20(19):7174-82. PubMed ID: 11007873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional solution structure of the calcium channel antagonist omega-agatoxin IVA: consensus molecular folding of calcium channel blockers.
    Kim JI; Konishi S; Iwai H; Kohno T; Gouda H; Shimada I; Sato K; Arata Y
    J Mol Biol; 1995 Jul; 250(5):659-71. PubMed ID: 7623383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of P-type calcium channel gating by the spider toxin omega-Aga-IVA.
    McDonough SI; Mintz IM; Bean BP
    Biophys J; 1997 May; 72(5):2117-28. PubMed ID: 9129813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and properties of omega-agatoxin IVB, a new antagonist of P-type calcium channels.
    Adams ME; Mintz IM; Reily MD; Thanabal V; Bean BP
    Mol Pharmacol; 1993 Oct; 44(4):681-8. PubMed ID: 8232218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega-agatoxin-TK containing D-serine at position 46, but not synthetic omega-[L-Ser46]agatoxin-TK, exerts blockade of P-type calcium channels in cerebellar Purkinje neurons.
    Kuwada M; Teramoto T; Kumagaye KY; Nakajima K; Watanabe T; Kawai T; Kawakami Y; Niidome T; Sawada K; Nishizawa Y
    Mol Pharmacol; 1994 Oct; 46(4):587-93. PubMed ID: 7969037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease treatment of cerebellar purkinje cells renders omega-agatoxin IVA-sensitive Ca2+ channels insensitive to inhibition by omega-conotoxin GVIA.
    Tringham EW; Dupere JR; Payne CE; Usowicz MM
    J Pharmacol Exp Ther; 2008 Feb; 324(2):806-14. PubMed ID: 17975010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A hot spot for the interaction of gating modifier toxins with voltage-dependent ion channels.
    Winterfield JR; Swartz KJ
    J Gen Physiol; 2000 Nov; 116(5):637-44. PubMed ID: 11055992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel peptide from funnel web spider venom, omega-Aga-TK, selectively blocks, P-type calcium channels.
    Teramoto T; Kuwada M; Niidome T; Sawada K; Nishizawa Y; Katayama K
    Biochem Biophys Res Commun; 1993 Oct; 196(1):134-40. PubMed ID: 8216284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatial distribution of omega-agatoxin IVA binding sites in mouse brain slices.
    Nakanishi S; Fujii A; Kimura T; Sakakibara S; Mikoshiba K
    J Neurosci Res; 1995 Jul; 41(4):532-9. PubMed ID: 7473885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of omega-agatoxin-IVA and omega-conotoxin-MVIIC on perineurial Ca++ and Ca(++)-activated K+ currents of mouse motor nerve terminals.
    Xu YF; Atchison WD
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1229-36. PubMed ID: 8968345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P-type calcium channels blocked by the spider toxin omega-Aga-IVA.
    Mintz IM; Venema VJ; Swiderek KM; Lee TD; Bean BP; Adams ME
    Nature; 1992 Feb; 355(6363):827-9. PubMed ID: 1311418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maturation of rat cerebellar Purkinje cells reveals an atypical Ca2+ channel current that is inhibited by omega-agatoxin IVA and the dihydropyridine (-)-(S)-Bay K8644.
    Tringham EW; Payne CE; Dupere JR; Usowicz MM
    J Physiol; 2007 Feb; 578(Pt 3):693-714. PubMed ID: 17124267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of omega-agatoxin IVA and its related peptides.
    Nishio H; Kumagaye KY; Kubo S; Chen YN; Momiyama A; Takahashi T; Kimura T; Sakakibara S
    Biochem Biophys Res Commun; 1993 Nov; 196(3):1447-53. PubMed ID: 8250902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the protective effects of a neuronal Cav2.1 calcium channel in brain injury.
    Kim TY; Yoshimoto T; Aoyama Y; Niimi K; Takahashi E
    Neuroscience; 2016 Jan; 313():110-21. PubMed ID: 26616403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative splicing generates a smaller assortment of CaV2.1 transcripts in cerebellar Purkinje cells than in the cerebellum.
    Kanumilli S; Tringham EW; Payne CE; Dupere JR; Venkateswarlu K; Usowicz MM
    Physiol Genomics; 2006 Jan; 24(2):86-96. PubMed ID: 16278278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of the antimicrobial peptide tachystatin A.
    Fujitani N; Kawabata S; Osaki T; Kumaki Y; Demura M; Nitta K; Kawano K
    J Biol Chem; 2002 Jun; 277(26):23651-7. PubMed ID: 11959852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presynaptic inhibition of synaptic transmission in the rat hippocampus by activation of muscarinic receptors: involvement of presynaptic calcium influx.
    Qian J; Saggau P
    Br J Pharmacol; 1997 Oct; 122(3):511-9. PubMed ID: 9351508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and characterization of a cyclooctapeptide analogue of ω-agatoxin IVB enhancing the activity of Cav2.1 calcium channels activity in cultured hippocampal neurons.
    Pringos E; Crouzin N; Cavalier M; Guiramand J; Cohen-Solal C; Martinez J; Vignes M; Rolland V
    Neurochem Int; 2012 Oct; 61(5):632-9. PubMed ID: 22819793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of verapamil and diltiazem on N-, P- and Q-type calcium channels mediating dopamine release in rat striatum.
    Dobrev D; Milde AS; Andreas K; Ravens U
    Br J Pharmacol; 1999 May; 127(2):576-82. PubMed ID: 10385261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.